Trial intelligence / Profile preview

EMDR vs SSRIs in PTSD

NCT06955845Completed

Start
May 2025
Primary completion
Nov 2025
Countries
1
01

Overview

Randomised trial in post-traumatic stress disorder (PTSD) (2 arms). Primary endpoint: Remission Rate at 6 weeks. Started May 2025; status: completed.

02

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT06955845.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06955845.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call